Clinical studies recruiting near Busan

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Phase N/A · Dong-A University Hospital · Eisai Korea Inc. · NCT06246123 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pusan National University Hospital · Pfizer · NCT06758401 Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Pusan National University Hospital · Walden Biosciences · NCT06466135 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Pusan National University Hospital · Hoffmann-La Roche · NCT06793215 Double Unit Cord Blood Transplant in Hematologic Malignancies.
Phase N/A · Seoul National University Hospital · NCT06712108 A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Phase 1 · Pusan National Univesity Hospital · Myeloid Therapeutics · NCT06478693 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Dong-A University Hospital · Eli Lilly and Company · NCT07415044 The DECISION-CTO Extended 10 Y Follow-up
Phase N/A · Dong-A Medical Center · Seung-Jung Park · NCT06908499 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Pusan National University Hospital · Eli Lilly and Company · NCT06890598 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Inje University Busan Paik Hospital · Regeneron Pharmaceuticals · NCT06091865 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Fore Biotherapeutics · NCT05503797 A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07357727 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Inje Univ Busan Paik Hospital · Loxo Oncology, Inc. · NCT05254743 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0106 · Celgene · NCT05519085 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Pusan National University Hospital · Gilead Sciences · NCT06051617 Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04)
Phase 3 · National Cancer Center, Korea · NCT05827523 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Pusan National University Hospital · Boehringer Ingelheim · NCT06531824 A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Inje University Haeundae Paik Hospital · Biogen · NCT06962800 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Pusan National University Hospital · Boehringer Ingelheim · NCT07220083 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Pusan National University Hospital · Kura Oncology, Inc. · NCT07007312 Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
NA · Yonsei University · NCT05490433 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Inje University Haeundae Paik Hospital · Eli Lilly and Company · NCT06338995 Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
Phase N/A · Seung-Jung Park · NCT03427996 Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea.
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06905288 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
Phase N/A · Seung-Jung Park · NCT01366404 Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent and/or Ultimaster Nagomi™ Stent in Routine Clinical
Phase N/A · Duk-Woo Park, MD · NCT04443530 A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of C
Phase 3 · Dong-A University Medical Center /ID# 279610 · AbbVie · NCT07525206 A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06564038 Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Phase 3 · Pusan National University Hospital · National Cancer Center, Korea · NCT04214990 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785

Look up another city

Look up another condition